Journal
ANNUAL REVIEW OF MEDICINE, VOL 63
Volume 63, Issue -, Pages 23-33Publisher
ANNUAL REVIEWS
DOI: 10.1146/annurev-med-062110-123753
Keywords
ethics; genetics; regulation; public perceptions
Categories
Ask authors/readers for more resources
Direct-to-consumer (DTC) genetic testing has attracted a great amount of attention from policy makers, the scientific community, professional groups, and the media. Although it is unclear what the public demand is for these services, there does appear to be public interest in personal genetic risk information. As a result, many commentators have raised a variety of social, ethical, and regulatory issues associated with this emerging industry, including privacy issues, ensuring that DTC companies provide accurate information about the risks and limitations of their services, the possible adverse impact of DTC genetic testing on healthcare systems, and concern about how individuals may interpret and react to genetic risk information.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available